Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Rijswijk, the Netherlands, Aug. 09, 2018 (GLOBE NEWSWIRE) -- Sustaining earlier momentum from its successful launches of generic versions of both Rosuvastatin and Atorvastatin earlier in 2018, DSM...
-
Rijswijk, 18 June 2018, June 18, 2018 (GLOBE NEWSWIRE) -- Building upon its first generic finished dosage statin launch (Rosuvastatin) in January of this year, DSM Sinochem Pharmaceuticals (DSP)...
-
新加坡, June 04, 2018 (GLOBE NEWSWIRE) --...
-
Rijswijk, Netherlands, March 20, 2018 (GLOBE NEWSWIRE) -- On the evening of March 20th, DSM Sinochem Pharmaceuticals (“DSP”), a global leader in the production of sustainable antibiotics, will host...
-
Rijswijk, Netherlands, Jan. 12, 2018 (GLOBE NEWSWIRE) -- Upon patent expiry at the end of December 2017, DSM Sinochem Pharmaceutical (DSP) has successfully launched its fully backward integrated,...
-
新加坡, Jan. 05, 2018 (GLOBE NEWSWIRE) -- 中化帝斯曼制药有限公司（DSP）今天宣布，中国国家知识产权局（SIPO）已签发关于DSP中国专利第200480007500.2号无效的决定。中化帝斯曼制药首席执行官Karl Rotthier说，“对于SIPO的决定，我们感到失望，但是我们将上诉至北京知识产权法院，我们相信北京知识产权法院将推翻上述行政决定”。 ...
-
DSM Sinochem Pharmaceuticals (DSP), the global leader in production and commercialization of sustainable, enzymatic antibiotics, next generation statins and anti-fungals, announced that it has filed a...
-
DSM Sinochem Pharmaceuticals (DSP), líder mundial en producción y comercialización de antibióticos enzimáticos sustentables, estatinas de nueva generación y antifúngicos, anunció que ha entablado una...
-
中化帝斯曼制药有限公司（简称“DSP”)是一家生产销售可持续、酶法抗生素、新一代他汀类药物和抗真菌药物的全球领先企业，日前宣布对石药集团有限公司、内蒙古常盛制药有限公司和石药中诺药业（石家庄）有限公司的专利侵权行为提起诉讼。 新加坡, Oct. 09, 2017 (GLOBE NEWSWIRE) --...